- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 20.59M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $15.13M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $15.41M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $1.13M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.13M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $12.66M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $21.03M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $8.56M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $13.15M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $26.3M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $31.6M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $93.11M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $97.97M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $211.45M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $218.16M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 20.94M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $1.04M |
| Capex | Q1 2025 · Mar 31, 2024 | $467K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.66M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $186.61M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $188.16M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.03 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.03 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $8.59M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$633K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.11M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $7.7M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $8.23M |
| Revenue | Q1 2025 · Mar 31, 2024 | $15.93M |